Marina Says Cash Will Run out at the End of the Month, Reports 2011 Financials | GenomeWeb

Roughly six months after stating that it could not file its 2011 annual report on time due to “financial and strategic uncertainties,” Marina Biotech has released its financial results for last year and, in doing so, disclosed that it will be out of money by the end of October.

As of Dec. 31, 2011, Marina had just $2 million in cash, $1 million of which was restricted, it said in filing with the US Securities and Exchange Commission released last week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.